MOONLAKE IMMUNOTHERAPEUTICS

Insiders MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq Other stock markets 01:29:52 31/05/2024 am IST			5-day change	1st Jan Change
41.11 ^USD	+0.07%		+2.88%	-31.93%

07/05	MoonLake Immunotherapeutics Q1 Net Loss Widens	MT
07/05	MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moonlake Immunotherapeutics Insider Sold Shares Worth $6,803,044, According to a Recent SEC Filing	01/03	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $6,540,710, According to a Recent SEC Filing	01/03	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $1,208,418, According to a Recent SEC Filing	23/02	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $5,917,368, According to a Recent SEC Filing	22/12	MT
Moonlake Immunotherapeutics Insider Bought Shares Worth $3,524,297, According to a Recent SEC Filing	11/23/11	MT
Moonlake Immunotherapeutics Insider Bought Shares Worth $16,800,343, According to a Recent SEC Filing	05/23/05	MT
Insider Buy: MoonLake Immunotherapeutics	29/23/29	MT
Insider Buy: MoonLake Immunotherapeutics	23/23/23	MT
Insider Buy: MoonLake Immunotherapeutics	08/22/08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer